{"filings":[{"id":555326,"accession_number":"0001213900-26-059557","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-05-20T20:30:21+00:00","items":["5.02","9.01"],"status":"ready","headline":"Modular Medical grants 15,892 stock options to CEO/CFO and COO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["11,218 options awarded to Chairman/President/CFO Paul DiPerna.","4,674 options awarded to COO Kevin Schmid.","Exercise price $3.46; vesting begins May 14, 2027 (1/3) then monthly (1/24).","Options expire on May 14, 2036; granted under Amended 2017 Equity Plan.","No departure or election; purely compensatory arrangement for named officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91111,"accession_number":"0001213900-26-045985","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical prices $3.4M offering of 750k shares at $4.50 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$3.4M from sale of 750,000 shares; closing expected April 21, 2026.","Offering priced at $4.50 per share under effective shelf registration S-3 (333-287313).","Maxim Group LLC is sole placement agent with a 7% fee and up to $75k expense reimbursement.","Directors and officers subject to 90-day lock-up; company restricted from new issuances for 45 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91110,"accession_number":"0001213900-26-044343","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Modular Medical regains Nasdaq minimum bid price compliance as of April 14, 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on April 15, 2026 confirming compliance with $1.00 minimum bid price requirement.","Closing bid price exceeded $1.00 for 10 consecutive trading days through April 14, 2026.","Nasdaq considers the matter closed; no further action required.","MODD common stock continues trading on the Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101032,"accession_number":"0001213900-26-037531","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Modular Medical announces 1-for-30 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split effective 5:30am ET March 31, 2026; trading on split-adjusted basis under MODD symbol.","Ratio: 1-for-30; outstanding shares reduced from 139,810,797 to approximately 4,660,360.","Purpose: increase per-share price to satisfy $1.00 minimum bid price for continued Nasdaq listing.","Authorized shares and par value unchanged; fractional shares paid in cash.","All equity awards and warrants adjusted proportionally (exercise price multiplied by 30)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101031,"accession_number":"0001213900-26-027652","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Modular Medical lays off 29% of workforce to cut annual costs by $3.4M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Layoff of 20 positions, representing ~29% of total workforce, effective March 12, 2026.","Expected annual operating expense reduction of approximately $3.4 million.","Non-recurring charges estimated at $0.1M–$0.2M, mainly severance; majority by June 30, 2026.","Company prioritizing higher-ROI projects to reduce cash burn."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101030,"accession_number":"0001213900-26-024671","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Modular Medical raises $12M via public offering of 68M shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$12M from sale of 68,098,000 shares (or pre-funded warrants) and 68,098,000 warrants at $0.1762/unit.","Warrants exercisable immediately at $0.1762, expire in five years.","Maxim Group LLC acted as sole placement agent; lock-up agreements for directors/officers for 90 days.","Offering closed March 4, 2026; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101029,"accession_number":"0001213900-26-019603","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","9.01","2.03"],"status":"ready","headline":"Modular Medical secures $350K revolving credit facility from CEO; 12% interest, secured by all assets","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$350,000 revolving credit facility from CEO James E. Besser (Manchester Explorer, L.P.).","12% interest; maturity March 25, 2026; secured by all assets and intellectual property.","No borrowings as of filing date; accelerated repayment if company receives >$2M equity proceeds.","Draw amounts minimum $50K; maximum $350K less outstanding; optional prepayment without penalty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101028,"accession_number":"0001213900-26-007296","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["3.03","5.03","5.07","9.01"],"status":"ready","headline":"Modular Medical shareholders approve 150% increase in authorized shares and reverse stock split authorization","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).","Board authorized to effect a reverse stock split at a ratio within a specified range within one year (Proposal 2: 50.6M for).","Equity incentive plan increased by 3M shares (Proposal 4: 35.38M for).","All eight director nominees elected, including CEO James Besser (not a candidate) and Duane DeSisto, Paul DiPerna, Steven Felsher, etc.","Farber Hass Hurley LLP ratified as independent auditor for fiscal year ending March 31, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117368,"accession_number":"0001213900-25-126825","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Modular Medical gets 180-day Nasdaq extension to June 29, 2026 to meet $1 bid price","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted 180-day extension under Rule 5810(c)(3)(A) after initial non-compliance notice on June 30, 2025.","Company must close at $1.00 or more for 10 consecutive business days by June 29, 2026 to regain compliance.","If compliance not met by deadline, Nasdaq will issue delisting notice; company may appeal to hearings panel.","Trading continues on Nasdaq Capital Market under MODD with no immediate effect from extension.","Company will monitor bid price and evaluate options to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117367,"accession_number":"0001213900-25-120759","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical raises $4.68M in underwritten public offering of stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offered 12,173,000 shares of common stock and warrants for 6,086,500 shares at combined price of $0.77 per unit.","Effective price of $0.38 per share and $0.01 per warrant; warrants exercisable at $0.45, expire in 5 years.","Gross proceeds of $4.68M; net proceeds to fund operations, working capital, and general corporate purposes.","Underwriter Newbridge Securities granted 30-day over-allotment option for up to 15% additional shares/warrants.","Directors and executive officers subject to 60-day lock-up; company subject to 90-day lock-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133794,"accession_number":"0001213900-25-090336","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Modular Medical induces warrant exercise for ~$3.7M gross; issues new warrants at premium","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Warrant holders exercise ~5.5M shares at $0.68/share (10% discount to NOCP), raising $3.7M.","Company issues ~2.75M new warrants (50% of exercised shares) with 5-year term at $0.84/share exercise price.","Newbridge Securities receives $400K fixed fee plus up to $50K expense reimbursement as servicing agent.","New warrants are unregistered and rely on Sections 3(a)(9) and 4(a)(2) exemptions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133793,"accession_number":"0001213900-25-061072","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Modular Medical receives Nasdaq minimum bid price deficiency notice; 180-day cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Company of bid price deficiency: closing bid below $1.00 for 30 consecutive business days ending June 27, 2025.","Company has 180 calendar days (until Dec 29, 2025) to regain compliance by achieving $1.00 close for ten consecutive business days.","If not compliant by deadline, Company may request second 180-day period with reverse stock split if eligible.","No immediate delisting; Company is evaluating options to address the deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150524,"accession_number":"0001213900-25-048276","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical appoints Jeff Goldberg, insulin delivery veteran, to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Jeff Goldberg to Board effective May 22, 2025.","Goldberg currently chairs Lannett Company, a generic pharma manufacturer that has launched generic insulin.","Previously served as President/CEO at IncuMed, Alfred E. Mann's incubator, overseeing insulin patch-pump program.","Also serves on boards of ATI Physical Therapy, Cano Health, and Eating Recovery Centers.","CEO Jeb Besser cited Goldberg's unique background at intersection of affordable drug-device combinations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169488,"accession_number":"0001013762-25-002793","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Modular Medical raises ~$12.5M in private placement; funds MODD1 tubeless FDA submission","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["6,247,656 Units at $1.92/Unit; each Unit = 2 common shares + 1 warrant (exercise $1.12, 4-yr term).","Concurrent direct placement of 260,417 Units for ~$0.5M to foreign investor under Regulation S.","Proceeds for general corporate, supply-chain, MODD1 tubeless FDA submission (target Q3 2025), CE mark.","Officers/directors purchased 374,478 Units; lock-up 60 days; no Variable Rate Transactions for 1 year.","Placement agent Newbridge receives 7.25% fee, $50k expenses, and 874,672 warrants at $1.40."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169487,"accession_number":"0001213900-25-019397","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Modular Medical holds 2025 annual meeting; elects 7 directors, approves equity plan increase and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 7 director nominees elected (Duane DeSisto, Paul DiPerna, Steven Felsher, Morgan Frank, Philip Sheibley, Carmen Volkart, Ellen O'Connor Vos).","Proposal 2 approved: amendment to 2017 Equity Incentive Plan increasing shares reserved by 3,000,000 shares (12,169,001 for, 7,488,354 against).","Proposal 3 ratified: Farber Hass Hurley LLP as independent auditor for FY ending March 31, 2025 (30,401,496 for, 14,273 against).","Approximately 74.9% of outstanding shares represented at meeting; broker non-votes noted on director election and equity plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186539,"accession_number":"0001213900-24-102121","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical closes $8.2M public offering of 5.45M shares at $1.50/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offered 5,450,573 shares at $1.50/share; gross proceeds ~$8.2M before expenses.","Underwriter Titan Partners received warrants for 381,540 shares at $1.875 exercise price.","CEO Jeb Besser's fund Manchester Explorer, largest shareholder, participated as existing institutional investor.","Proceeds to fund operations, working capital, and general corporate purposes.","Lock-up agreements for 60 days from close on Nov 25, 2024; company restricted from issuing equity for 60 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203115,"accession_number":"0001213900-24-075772","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Modular Medical gets FDA clearance for MODD1 insulin pump; launch expected early 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA cleared the MODD1 patch pump for all adults with Type 1 and Type 2 diabetes.","Pump designed to be simpler and more affordable to expand access to underserved diabetes communities.","Commercial availability expected in early 2025; manufacturing infrastructure substantially established.","Company plans a conference call to discuss clearance and next steps (details TBA)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203114,"accession_number":"0001213900-24-072999","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Modular Medical missed FDA clearance deadline for MODD-1; grants new options with Dec 31, 2024 vesting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Milestone 2 options (FDA clearance by Aug 1, 2024) canceled on Aug 2, 2024; no clearance received.","On Aug 22, 2024, granted 58,560 options to Paul DiPerna and 24,400 to Kevin Schmid at $1.71 strike.","Also granted options for 256,338 shares to non-executive employees, same $1.71 strike and vesting conditions.","New options vest only if FDA notification received by Dec 31, 2024; otherwise terminate Jan 1, 2025.","Previous Milestone 1 options (Jan 19, 2024) vested; exercise price was $1.11."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219410,"accession_number":"0001213900-24-031921","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-04-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Modular Medical raises salaries for President DiPerna & COO Schmid; grants 150k total options","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paul DiPerna's base salary increased from $300k to $360k retroactive April 1, 2024; title changed from CEO to President.","Kevin Schmid's base salary increased from $250k to $300k retroactive April 1, 2024.","DiPerna granted option for 100k shares at $1.52, vesting 1/3 after one year then monthly over 3 years.","Schmid granted option for 50k shares at $1.52 on same vesting schedule.","Total options granted: 150k shares under Amended 2017 Equity Incentive Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239246,"accession_number":"0001213900-24-014985","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical prices $10M public offering of 9.09M shares at $1.10 per share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Priced 9,090,910 shares at $1.10/share for $10M gross proceeds; over-allotment option for 1,321,989 additional shares.","Offering led by Manchester Explorer, managed by CEO Jeb Besser and director Morgan Frank, plus other institutions.","Net proceeds to fund operations, working capital, and general corporate purposes; closing expected Feb 21, 2024.","Directors/executive officers subject to lock-up until May 21, 2024, prohibiting sale of securities without underwriter consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239245,"accession_number":"0001213900-24-014542","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["3.03","5.03","5.07","8.01","9.01"],"status":"ready","headline":"Modular Medical increases authorized shares to 100M and suspends ATM equity program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 50M to 100M via charter amendment effective Feb 15, 2024.","Annual meeting approved share increase, equity plan adding 3M shares, and auditor ratification.","ATM equity sales suspended effective Jan 29, 2024; no sales until new prospectus supplement filed.","All six director nominees elected with over 11.6M votes each; ~65.8% quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239244,"accession_number":"0001213900-24-004669","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2024-01-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Modular Medical submits MODD1 insulin pump to FDA for 510(k) clearance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Submitted MODD1 next-generation insulin pump to FDA for 510(k) clearance on Jan 19, 2024.","Expects initial FDA questions during quarter ending June 30, 2023 (as stated in press release).","Plans to file for UKCA mark to market MODD1 in the United Kingdom.","CEO Jeb Besser and Chairman Paul DiPerna highlighted simplified design to boost pump adoption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256750,"accession_number":"0001213900-23-098330","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-12-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Modular Medical posts investor presentation; no specific new data provided in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company posted an investor presentation on its website on December 26, 2023.","Presentation expected to be used in meetings with investors, brokers, and analysts.","No specific financial or operational updates were included in the filing's exhibit text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256749,"accession_number":"0001213900-23-089664","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-11-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Modular Medical enters into $6.5M ATM sales agreement with Leerink Partners","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement allows sale of common stock from time to time for up to $6.5M in gross proceeds.","Leerink will receive a 3% commission on gross proceeds from shares sold.","Shares offered under existing S-3 shelf registration; Company has no obligation to sell.","Company may suspend or terminate sales at any time in its sole discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256748,"accession_number":"0001013762-23-002171","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-10-05T23:59:59+00:00","items":["3.02","5.02","9.01"],"status":"ready","headline":"Modular Medical adopts FDA milestone bonus program; execs get options tied to MODD-1 clearance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Besser receives 135,136 options for 510(k) submission by Jan 31, 2024; no options for clearance milestone.","Chairman/CFO DiPerna gets 90,091 submission options + 45,046 clearance options; COO Schmid gets 37,538 + 18,769.","Options priced at $1.11/share, 10-year term; cancellable if milestones missed.","Non-executive employee aggregate bonus pool ~$757,000 in cash or options at employee election.","Milestone 2 requires FDA clearance of MODD-1 insulin pump by August 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274108,"accession_number":"0001213900-23-055629","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-07-10T23:59:59+00:00","items":["3.02","5.02","9.01"],"status":"ready","headline":"Modular Medical appoints former Insulet CEO Duane DeSisto to board; William Febbo resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William Febbo resigned from the board effective July 5, 2023; not due to any disagreement.","Duane DeSisto appointed to board and to chair Compensation Committee, effective July 5, 2023.","DeSisto was President & CEO of Insulet (OmniPod pump) from 2001–2014; grew market cap to >$2B.","DeSisto received an RSU for 250,000 shares vesting quarterly over three years.","As non-employee director, DeSisto will get $30K annual cash/equity plus $100K annual equity award."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291281,"accession_number":"0001213900-23-040917","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-05-17T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical prices upsized $9.4M public offering of units at $2.13/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 8,816,900 common shares and warrants for 4,408,450 shares at $2.13/unit yields gross $9.4M.","Net proceeds ~$8.3M; warrants exercisable at $1.22 for five years.","Funds to finance operations through FDA approval, sales/marketing infrastructure, R&D, manufacturing.","Underwriter Newbridge Securities; expected close May 18, 2023.","30-day over-allotment option for up to 1,322,534 shares and 661,267 warrants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312079,"accession_number":"0001019056-23-000039","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-01-19T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Shareholders elect all 7 directors and approve 2M-share equity plan increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected: DiPerna, Febbo, Felsher, Frank, Sheibley, Volkart, O'Connor Vos.","Amendment to 2017 Equity Plan adding 2M shares approved: 6,135,990 for, 156,846 against.","Farber Hass Hurley LLP ratified as auditor for FY2023: 7,814,759 for, 39 against.","Non-binding advisory vote on executive compensation passed; three-year frequency recommended (5,664,961 votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312078,"accession_number":"0001019056-23-000027","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2023-01-11T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Modular Medical enters 48-month lease for 24,000 sq ft in San Diego","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Monthly base rent $36,000 for first 12 months, increasing 4% annually thereafter.","Plus common area charges of approximately $10,700/month, adjustable based on actual costs.","Lease term 48 months beginning on or about February 1, 2023, at 10740 Thornmint Road.","Lessor is Michael Summers; property includes 24,000 square feet of space."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348159,"accession_number":"0001019056-22-000518","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["3.02","5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical appoints Kevin Schmid as COO; $250K salary, 175K share option","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Schmid appointed COO on July 21, 2022, effective immediately.","Annual salary $250,000 with discretionary target bonus up to 50% of base salary.","Granted option for 175,000 shares vesting over 3 years; 1/3 at one year, then monthly.","Severance: six months salary if terminated without cause. Previously VP at Insulet, CEO at Common Sensing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348158,"accession_number":"0001019056-22-000516","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-07-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Modular Medical amends director comp plan; sets $10 floor for equity grants","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Outside directors get $25k annual retainer for board service; $25k for chair; $5k for committee chair.","Annual equity award of $100k per director, paid quarterly in options or shares at director election.","Equity grants priced using $10 floor if penultimate quarter closing price is below $10.","Amended plan approved July 19, 2022; replaces original plan from May 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364826,"accession_number":"0001019056-22-000448","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-06-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Modular Medical posts investor presentation on website; no new financial guidance disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company filed Form 8-K indicating it posted an investor presentation on June 13, 2022.","Presentation attached as Exhibit 99.1, but no specific financial metrics or strategic updates provided in the filing.","Presentation expected to be used with investors, brokers, and analysts; content not fully disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364825,"accession_number":"0001019056-22-000371","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Modular Medical raises $8M via registered direct offering with Sio Capital Management","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering: 449,438 shares at $4.45/share and pre-funded warrants for 1,348,314 shares at $4.44/warrant.","Private placement warrants for 1,438,202 shares at $6.60 exercise price, exercisable after 6 months for 5 years.","Gross proceeds $8M; net ~$7.4M; use for operations, product development, working capital.","Expected close May 5, 2022; Oppenheimer & Co. placement agent; 90-day equity issuance lock-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364824,"accession_number":"0001019056-22-000321","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-04-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Modular Medical gets Oppenheimer waiver to file shelf registration before lock-up end","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Oppenheimer & Co. waived lock-up to allow Modular Medical to file Form S-3 shelf registration for equity/debt securities.","Waiver covers only filing; sales or prospectus supplements before lock-up expiry need Oppenheimer's written consent.","Lock-up period started Feb 9, 2022 (180 days); waiver granted March 28, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384440,"accession_number":"0001019056-22-000236","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-02-25T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical CEO resigns; largest shareholder's Jeb Besser appointed CEO; reaffirms FDA timeline","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Ellen O'Connor Vos resigned effective Feb 23, 2022; she remains on the board.","James 'Jeb' Besser appointed CEO; compensation is $1 per year; Besser is managing member of largest shareholder Manchester Management.","Severance agreement provides Vos $375,000 gross payment; unvested option on 362,452 shares forfeited after May 24, 2022.","Company reaffirms Q2 2022 timing for MODD1 insulin pump 510(k) submission to FDA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384439,"accession_number":"0001019056-22-000231","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-02-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Modular Medical posts investor presentation; no specific financial or operational updates disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company posted investor presentation to its website on February 24, 2022.","Presentation may be used in communications with investors, brokers, and analysts.","No new financial results, guidance, or material events were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384438,"accession_number":"0001019056-22-000180","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-02-14T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical raises $15M in public offering, uplists to Nasdaq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Priced public offering of 2.5M units at $6.00/unit for gross proceeds of $15M; each unit = 1 share + 1 warrant.","Common stock approved for listing on Nasdaq Capital Market under MODD; trading began Feb 10, 2022.","Warrants exercisable immediately at $6.60/share, expire in 5 years; shares and warrants separately tradeable.","Net proceeds for working capital, sales & marketing infrastructure, R&D, manufacturing, and repayment of promissory note.","Offering closed Feb 14, 2022; underwriters led by Oppenheimer & Co., with Benchmark and Lake Street as co-lead managers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384437,"accession_number":"0001019056-22-000025","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2022-01-04T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Director Liam Burns resigns from Modular Medical Board; Board forms Nominating Committee","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Liam Burns resigned as board member effective Dec 31, 2021; no disagreement with the Company.","Board approved formation of Nominating and Corporate Governance Committee, appointing Philip Sheibley (chair) and Steven Felsher.","Committee charters for Audit, Compensation, and Nominating Committees adopted and posted on Company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402299,"accession_number":"0001019056-21-000626","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-12-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical appoints Steven Felsher and Philip Sheibley to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective November 29, 2021, appointed Steven Felsher and Philip Sheibley as independent directors.","Each director received an initial option to purchase 50,000 shares, vesting ratably over three years.","Annual compensation: $30,000 retainer plus $100,000 equity award, payable quarterly in cash or stock.","Felsher brings finance and governance experience; Sheibley brings life sciences and venture capital expertise.","No family relationships or related party transactions exceeding $120,000 involving the appointees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402298,"accession_number":"0001019056-21-000620","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-12-01T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Modular Medical announces 1-for-3 reverse stock split to meet Nasdaq listing price requirement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split ratio 1-for-3; effective Nov 29, 2021; trading symbol temporarily changes to MODDD.","Split intended to fulfill Nasdaq's $4.00 minimum bid price requirement for proposed uplisting.","No fractional shares issued; any fractions rounded up to nearest whole share.","Authorized shares unchanged; stockholders in brokerage accounts need no action.","Uplisting not guaranteed; other Nasdaq listing requirements must still be satisfied."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402297,"accession_number":"0001019056-21-000551","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-10-29T23:59:59+00:00","items":["1.01","9.01","2.03","3.02"],"status":"ready","headline":"Modular Medical secures $3M revolving credit facility at 12%; officers buy $250k in stock","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["CEO Ellen O'Connor Vos and Chairman Paul DiPerna purchased 92,592 shares at $2.70/share for $250,000 total.","Company entered $3M revolving credit facility with Manchester Explorer L.P., secured by all assets.","Interest rate 12% on drawn amounts; maturity March 15, 2022; no draws to date.","Principal must be repaid earlier if company raises >$12M in equity before maturity.","Event of default allows acceleration; note is secured by first priority lien on all property."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":421246,"accession_number":"0001019056-21-000508","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-09-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Modular Medical posts investor presentation to website","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation posted to www.modular-medical.com on September 29, 2021.","Presentation expected to be used in discussions with investors, brokers, and analysts.","No specific financial or operational updates from the presentation are included in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":421245,"accession_number":"0001019056-21-000496","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-09-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Chief Commercial Officer Stephen Daly resigns, effective Sept 24; consulting arrangement planned","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen Daly resigned as Chief Commercial Officer, effective on or about September 24, 2021.","Resignation not due to any disagreement with the Company on operations, policies, or practices.","Company and Daly intend to enter into a consulting agreement for transitional services on a part-time interim basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":421244,"accession_number":"0001019056-21-000475","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2021-08-16T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical appoints Lynn O'Connor Vos as CEO; founder DiPerna becomes Chairman and President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paul DiPerna resigned as CEO effective Aug 11, 2021; remains Chairman, President, CFO, Secretary.","Ellen O'Connor Vos appointed CEO; employment agreement: $250k cash + $50k deferred salary, $300k performance bonus.","Vos granted option to purchase 1,087,354 shares at $4.06 (closing Aug 10); vesting 20% after 6 months, rest over 42 months.","Vos previously CEO of Muscular Dystrophy Association and ghg|greyhealth group; focuses on digital health and patient advocacy.","Company is development-stage insulin pump firm targeting commercial launch in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":26406542.46530612,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}